Show
Sort by
-
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT) : a prospective study from the Belgian Hematology Society (BHS)
-
Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature
-
- Journal Article
- A1
- open access
Chimeric antigen receptor-T-cell therapy for B-cell hematological malignancies : an update of the pivotal clinical trial data
-
Results from the phase I clinical studies evaluating Cyad-01, a first-generation NKG2D CAR T-cell product in relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome patients
-
Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients : a report from the EBMT Severe Aplastic Anemia Working Party
-
Allogeneic hematopoietic cell transplantation for acute myeloid leukemia following total body irradiation : the effect of anti-thymocyte globulin on transplant outcome : ALWP of the EBMT study
(2019) BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. In Biology of Blood and Marrow Transportation 25(3). p.S187-S187 -
- Journal Article
- A1
- open access
Impact of antithymocyte globulin on outcomes of allogeneic hematopoietic cell transplantation with TBI
-
- Conference Paper
- C3
- open access
Results from the completed dose-escalation of the hematological arm of the Phase I Think Study evaluating multiple infusions of NKG2D-based CAR T-cells as standalone therapy in relapse/refractory acute myeloid leukemia and myelodysplastic syndrome patients
-
Multipotent mesenchymal stromal cells for poor graft function after allogeneic hematopoietic cell transplantation : a multicenter prospective study
-
Providing both autologous and allogeneic hematopoietic stem cell transplants (HSCT) may have a stronger impact on the outcome of autologous HSCT in adult patients than activity levels or implementation of JACIE at Belgian transplant centres